Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 12, 2013, Pages 7544-7556

  Mead, Ben ^a   Logan, Ann ^a   Berry, Martin ^a   Leadbeater, Wendy ^a   Scheven, Ben A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Axon regeneration; Cell transplantation; Dental pulp stem cells; Mesenchymal stem cells; Neuroprotection

Indexed keywords

BETA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; DENTAL PULP STEM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINAL NERVE FIBER LAYER THICKNESS; STEM CELL; STEM CELL TRANSPLANTATION;

AXON REGENERATION; CELL TRANSPLANTATION; DENTAL PULP STEM CELLS; MESENCHYMAL STEM CELLS; NEUROPROTECTION;

ANIMALS; AXONS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCULTURE TECHNIQUES; DENTAL PULP; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MESENCHYMAL STROMAL CELLS; NERVE GROWTH FACTOR; NERVE REGENERATION; NEUROTROPHIN 3; OPTIC NERVE INJURIES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; STEM CELL TRANSPLANTATION; STEM CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VITREOUS BODY;

EID: 84887853164     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13045     Document Type: Article

References (49)

1. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord. 2006; 44: 523-529.
2. Ghajar J. Traumatic brain injury. Lancet. 2000; 356: 923-929.
3. Sarkies N. Traumatic optic neuropathy. Eye. 2004; 18: 1122-1125.
4. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997; 275: 668-670.
5. Richardson PM, McGuinness UM, Aguayo AJ. Axons from CNS neurones regenerate into PNS grafts. Nature. 1980; 284: 264-265.
6. Berry M, Ahmed Z, Lorber B, Douglas M, Logan A. Regeneration of axons in the visual system. Restor Neurol Neurosci. 2008; 26: 147-174.
7. Schwab M, Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci. 1988; 8: 2381-2393.
8. Caroni P, Schwab ME. Antibody against myelin associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1988; 1: 85-96.
9. Benowitz LI, Yin Y. Combinatorial treatments for promoting axon regeneration in the CNS: strategies for overcoming inhibitory signals and activating neurons' intrinsic growth state. Dev Neurobiol. 2007; 67: 1148-1165.
10. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993; 602: 304-317.
11. Ahmed Z, Kalinski H, Berry M, et al. Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis. 2011; 2.
12. Ko ML, Hu DN, Ritch R, Sharma SC. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000; 41: 2967-2971.
13. Ko ML, Hu DN, Ritch R, Sharma SC, Chen CF. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett. 2001; 305: 139-142.
14. Sommerfeld MT, Schweigreiter R, Barde YA, Hoppe E. Downregulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J Biol Chem. 2000; 275: 8982-8990.
15. Chen H, Weber AJ. Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats. Brain Res. 2004; 1011: 99-106.
16. Logan A, Ahmed Z, Baird A, Gonzalez AM, Berry M. Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain. 2006; 129: 490-502.
17. Thomas KE, Moon LDF. Will stem cell therapies be safe and effective for treating spinal cord injuries? Br Med Bull. 2011; 98: 127-142.
18. Abematsu M, Tsujimura K, Yamano M, et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J Clin Invest. 2010; 120: 3255-3266.
19. Gu W, Zhang F, Xue Q, Ma Z, Lu P, Yu B. Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology. 2010; 30: 205-217.
20. Dormady SP, Bashayan O, Dougherty R, Zhang XM, Basch RS. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res. 2001; 10: 125-140.
21. Sakai K, Yamamoto A, Matsubara K, et al. Human dental pulpderived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuroregenerative mechanisms. J Clin Invest. 2012; 122: 80-90.
22. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. 2009; 3: 63-70.
23. Levkovitch-Verbin H, Sadan O, Vander S, et al. Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci. 2010; 51: 6394-6400.
24. Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, Martin KR. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci. 2010; 51: 2051-2059.
25. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000; 97: 13625-13630.
26. Chai Y, Jiang X, Ito Y, et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development. 2000; 127: 1671-1679.
27. Kiraly M, Porcsalmy B, Pataki A, et al. Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons. Neurochem Int. 2009; 55: 323-332.
28. Arthur A, Rychkov G, Shi S, Koblar SA, Gronthos S. Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells. 2008; 26: 1787-1795.
29. Kiraly M, Kadar K, Horvathy DB, et al. Integration of neuronally predifferentiated human dental pulp stem cells into rat brain in vivo. Neurochem Int. 2011; 59: 371-381.
30. Gale Z, Cooper PR, Scheven BAA. Effects of glial cell linederived neurotrophic factor on dental pulp cells. J Dent Res. 2011; 90: 1240-1245.
31. Nosrat IV, Widenfalk J, Olson L, Nosrat CA. Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury. Dev Biol. 2001; 238: 120-132.
32. Nosrat CA, Fried K, Lindskog S, Olson L. Cellular expression of neurotrophin mRNAs during tooth development. Cell Tissue Res. 1997; 290: 569-580.
33. Huang AH-C, Snyder BR, Cheng P-H, Chan AWS. Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells. 2008; 26: 2654-2663.
34. Basso DM, Beattie MS, Bresnahan JCA. Sensitive and reliable locomotor rating-scale for open-field testing in rats. J Neurotrauma. 1995; 12: 1-21.
35. Leong WK, Henshall TL, Arthur A, et al. Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med. 2012; 1: 177-187.
36. Douglas MR, Morrison KC, Jacques SJ, et al. Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth. Brain. 2009; 132: 3102-3121.
37. Berry M, Carlile J, Hunter A, Tsang WL, Rosustrel P, Sievers J. Optic nerve regeneration after intravitreal peripheral nerve implants: trajectories of axons regrowing through the optic chiasm into the optic tracts. J Neurocytol. 1999; 28: 721-741.
38. Sullivan KF. Structure and utilization of tubulin isotypes. Annu Rev Cell Biol. 1988; 4: 687-716.
39. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerveinjured retinas. Invest Ophthalmol Vis Sci. 2009; 50: 3860-3868.
40. Berry M, Carlile J, Hunter A. Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J Neurocytol. 1996; 25: 147-170.
41. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994; 14: 4368-4374.
42. Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, Vidal-Sanz M. Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res. 2009; 89: 32-41.
43. Logan A, Ahmed Z, Baird A, Gonzalez AM, Berry M. Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain. 2006; 129: 490-502.
44. Ahmed Z, Dent RG, Leadbeater WE, Smith C, Berry M, Logan A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol Cell Neurosci. 2005; 28: 64-78.
45. Ahmed Z, Suggate EL, Brown ER, et al. Schwann cell-derived factor-induced modulation of the NgR/p75NTR/EGFR axis disinhibits axon growth through CNS myelin in vivo and in vitro. Brain. 2006; 129: 1517-1533.
46. Fischer D. CNTF: a key factor mediating the beneficial effects of inflammatory reactions in the eye. Brain. 2008; 131: e97.
47. Muller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D. Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol Cell Neurosci. 2009; 41: 233-246.
48. Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2002; 43: 3292-3298.
49. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A. 2006; 103: 3896-3901.